Who
Patricia B. Prichep
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Cel-Sci.
In numbers
- Trades disclosed
- 132
- Buys
- 4
- Sells
- 0
- Bought
- $51K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 30 Dec 2005
- Last trade
- 30 Sep 2026
- Last filed
- 1 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 30 Sep 2026filed 1 Oct 2026 | CVM Cel-SciBiotechnology | SEC FORM 4 Code A | $4,2892,082 at $2.06 | filing |
| 14 Aug 2026filed 17 Aug 2026 | CVM Cel-Scioption or derivative · Biotechnology | SEC FORM 4 Code A | $2,250225,000 at $0.01 | filing |
| 14 Aug 2026filed 17 Aug 2026 | CVM Cel-Scioption or derivative · Biotechnology | SEC FORM 4 Code A | $2,250225,000 at $0.01 | filing |
| 30 Jun 2026filed 1 Jul 2026 | CVM Cel-SciBiotechnology | SEC FORM 4 Code A | $4,2904,125 at $1.04 | filing |
| 30 Jun 2026filed 1 Jul 2026 | CVM Cel-SciBiotechnology | SEC FORM 4 Code A | $4,2904,125 at $1.04 | filing |
| 31 Mar 2026filed 1 Apr 2026 | CVM Cel-SciBiotechnology | SEC FORM 4 Code A | $4,2891,336 at $3.21 | filing |
| 31 Mar 2026filed 1 Apr 2026 | CVM Cel-SciBiotechnology | SEC FORM 4 Code A | $4,2891,336 at $3.21 | filing |
| 31 Dec 2025filed 5 Jan 2026 | CVM Cel-SciBiotechnology | SEC FORM 4 Code A | $4,287815 at $5.26 | filing |
| 31 Dec 2025filed 5 Jan 2026 | CVM Cel-SciBiotechnology | SEC FORM 4 Code A | $4,287815 at $5.26 | filing |
| 30 Sep 2025filed 2 Oct 2025 | CVM Cel-SciBiotechnology | SEC FORM 4 Code A | $4,287466 at $9.20 | filing |
| 28 Jul 2025filed 29 Jul 2025 | CVM Cel-Scioption or derivative · Biotechnology | SEC FORM 4 Code A | $12012,000 at $0.01 | filing |
| 30 Jun 2025filed 1 Jul 2025 | CVM Cel-SciBiotechnology | SEC FORM 4 Code A | $4,2891,873 at $2.29 | filing |
| 31 Mar 2025filed 1 Apr 2025 | CVM Cel-SciBiotechnology | SEC FORM 4 Code A | $3,54915,432 at $0.23 | filing |
| 31 Dec 2024filed 2 Jan 2025 | CVM Cel-SciBiotechnology | SEC FORM 4 Code A | $4,29110,727 at $0.40 | filing |
| 30 Sep 2024filed 1 Oct 2024 | CVM Cel-SciBiotechnology | SEC FORM 4 Code A | $4,2904,047 at $1.06 | filing |
| 28 Jun 2024filed 1 Jul 2024 | CVM Cel-SciBiotechnology | SEC FORM 4 Code A | $4,2903,698 at $1.16 | filing |
| 8 May 2024filed 9 May 2024 | CVM Cel-SciBiotechnology | SEC FORM 4 Bought | $11K8,000 at $1.39 | filing |
| 19 Apr 2024filed 23 Apr 2024 | CVM Cel-Scioption or derivative · Biotechnology | SEC FORM 4 Code A | $1,670167,000 at $0.01 | filing |
| 29 Mar 2024filed 2 Apr 2024 | CVM Cel-SciBiotechnology | SEC FORM 4 Code A | $4,2902,246 at $1.91 | filing |
| 29 Dec 2023filed 2 Jan 2024 | CVM Cel-SciBiotechnology | SEC FORM 4 Code A | $4,2891,577 at $2.72 | filing |
News
No headline names them, or the companies they trade most, lately.